These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19121794)

  • 1. Value of implantable cardioverter-defibrillators in managing atrial fibrillation.
    Frisch DR
    Heart Rhythm; 2009 Jan; 6(1):9-10. PubMed ID: 19121794
    [No Abstract]   [Full Text] [Related]  

  • 2. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.
    Bunch TJ; Day JD; Olshansky B; Stolen KQ; Mullin CM;
    Heart Rhythm; 2009 Jan; 6(1):2-8. PubMed ID: 18996055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R; Shah AJ; Keebler M; Thakur RK
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic capabilities of devices for cardiac resynchronization therapy.
    Gardini A; Lupo P; Zanelli E; Bisetti S; Cappato R
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):186-9. PubMed ID: 19829134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrillation testing in patients with atrial fibrillation.
    Lim HS; Lip GY
    Europace; 2009 Aug; 11(8):1108-9. PubMed ID: 19549676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral analysis of the electrocardiogram predicts recurrence of atrial fibrillation after cardioversion.
    Langberg JJ; Burnette JC; McTeague KK
    J Electrocardiol; 1998; 31 Suppl():80-4. PubMed ID: 9988009
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic significance of implantable defibrillator shock: are all shocks created equal?
    Freedberg NA; Feldman A
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):741-3. PubMed ID: 22494054
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
    Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ultrasound view on the substrate for incident and recurrent atrial fibrillation in heart failure patients.
    Kirchhof P; Fabritz L; Tiemann K
    Eur J Heart Fail; 2010 Oct; 12(10):1019-20. PubMed ID: 20861129
    [No Abstract]   [Full Text] [Related]  

  • 12. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction to atrial fibrillation and heart failure: a mutually noxious association.
    Daubert JC
    Europace; 2004 Sep; 5 Suppl 1():S1-4. PubMed ID: 15450274
    [No Abstract]   [Full Text] [Related]  

  • 14. Atrial fibrillation in heart failure in the older population.
    Heck PM; Lee JM; Kistler PM
    Heart Fail Clin; 2013 Oct; 9(4):451-9, viii-ix. PubMed ID: 24054478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ice vs. fire: cryoballoon ablation for the prevention of inappropriate implantable cardioverter-defibrillator shocks in a 14-year-old girl with Brugada syndrome.
    Conte G; Chierchia GB; Levinstein M; Brugada P
    Europace; 2013 Dec; 15(12):1804. PubMed ID: 23599168
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [About an implantable cardioverter-fibrillator].
    Douchet MP; Bakouboula B; Bronner F; Chauvin M
    Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):290-1. PubMed ID: 21663891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
    Lehmann MH; Aaronson KD
    J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
    [No Abstract]   [Full Text] [Related]  

  • 19. Atrial fibrillation and heart failure.
    Larned JM; Raja Laskar S
    Congest Heart Fail; 2009; 15(1):24-30. PubMed ID: 19187404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
    Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
    Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.